Dacarbazine Injection

Get a Price/Quote

Product Details:

Salt Composition Dacarbazine
Indication Antineoplastic agent used in the treatment of melanoma and Hodgkins lymphoma
Dosage Form Injection
Feature Sterile, single-use vial
Ingredients Dacarbazine, excipients, sterile water for injection
Application
Ph Level 3.0 4.0
Click to View more

Request to Call Back Send Inquiry

Product Details
Product Description

Dacarbazine Injection Price And Quantity

Reconstitution Instructions Reconstitute with sterile water for injection before use
Contraindications Hypersensitivity to Dacarbazine or any component of the formulation
pH Adjusting Agents May contain hydrochloric acid for pH adjustment
Disposal Instructions Dispose of unused product and waste materials in accordance with local regulations
Packaging Type Glass vial with flip-off seal
Marketed By BRG Biomedicals
Strength 200 mg/vial or 500 mg/vial (as indicated on packaging)
Usage Caution Strictly for use under medical supervision
Registration Status Approved under prescription only
Route of Administration Intravenous infusion
Category Antineoplastic (Anti-cancer medication)

Dacarbazine Injection Product Specifications

Storage Instructions Store below 25C, protect from light
Fermentation Smell Odorless
Dosage Form Injection
Ph Level 3.0 4.0
Physical Color/Texture White to off-white lyophilized powder
Indication Antineoplastic agent used in the treatment of melanoma and Hodgkins lymphoma
Salt Composition Dacarbazine
Feature Sterile, single-use vial
Enzymatic Activity No enzymatic activity
Ingredients Dacarbazine, excipients, sterile water for injection
Shelf Life 36 months

Reconstitution Instructions Reconstitute with sterile water for injection before use
Contraindications Hypersensitivity to Dacarbazine or any component of the formulation
pH Adjusting Agents May contain hydrochloric acid for pH adjustment
Disposal Instructions Dispose of unused product and waste materials in accordance with local regulations
Packaging Type Glass vial with flip-off seal
Marketed By BRG Biomedicals
Strength 200 mg/vial or 500 mg/vial (as indicated on packaging)
Usage Caution Strictly for use under medical supervision
Registration Status Approved under prescription only
Route of Administration Intravenous infusion
Category Antineoplastic (Anti-cancer medication)

Dacarbazine Injection Trade Information

Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

Established in the year 1991, we have emerged as one of the reputed organizations engaged in offering Dacarbazine Injection. Doctors prescribe it for the treatment of skin cancer that has spread to other parts of the body. It is also used in combination with other anti cancer medications to treat cancer of the white blood cell. Our dexterous agents source this drug from the most authentic vendors of the market. We offer Dacarbazine Injection at affordable prices to clients.

Features:

Slows the growth of cancer cells
Blocks the action of the abnormal protein
Accurate composition

How Dacarbazine Injection Works

Dacarbazine Injection acts as an antineoplastic agent, interfering with the growth of rapidly dividing cancer cells. By disrupting the DNA structure within these cells, it helps to slow or halt the progression of malignancies, particularly melanoma and Hodgkins lymphoma. Its use is strictly controlled and must be supervised by a qualified healthcare provider to ensure safety and efficacy.

Preparation and Administration

This medication is supplied as a lyophilized powder and requires reconstitution with sterile water for injection before being administered as an intravenous infusion. It is packaged in a sealed glass vial to maintain sterility and must be prepared and given by medical professionals in a clinical setting. Each vial is single-use only, minimizing the risk of contamination.

Safety and Proper Disposal

Only individuals who do not have a known hypersensitivity to dacarbazine or any component of its formulation should receive this product. After administration, any remaining drug or waste material must be disposed of according to local regulations. Following recommended safety guidelines protects both patients and the environment from potential risks associated with cytotoxic agents.

FAQs of Dacarbazine Injection:

Q: How should Dacarbazine Injection be prepared before administration?

A: Dacarbazine Injection must be reconstituted with sterile water for injection. The correct volume of sterile water, as indicated in the product literature, should be added to the vial and gently mixed until completely dissolved, resulting in a clear solution. Only a healthcare professional should handle the preparation process.

Q: What are the indications for using Dacarbazine Injection?

A: This medication is indicated as part of cancer chemotherapy for the treatment of malignant melanoma and Hodgkins lymphoma. Its use is based on a doctors assessment and prescription.

Q: When should Dacarbazine Injection not be used?

A: Dacarbazine Injection is contraindicated in patients who have hypersensitivity to dacarbazine or any of its components. It should not be administered to individuals with known allergies to the formulation.

Q: Where should Dacarbazine Injection be stored prior to use?

A: The vials should be stored below 25C and protected from light. The product should be kept in its original packaging until reconstitution and should not be used past its expiration date, which is 36 months from the manufacturing date.

Q: What are the benefits of Dacarbazine Injection in cancer treatment?

A: As an antineoplastic (anti-cancer) medication, Dacarbazine Injection has demonstrated efficacy in slowing the growth and spread of certain cancers, contributing to improved outcomes in patients with melanoma or Hodgkins lymphoma.

Q: How should unused or discarded Dacarbazine Injection be disposed of?

A: Any unused product, reconstituted solution, or waste materials must be disposed of safely according to local regulations for cytotoxic drugs. Healthcare professionals are responsible for ensuring proper disposal.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Injections' category

Atgam Injection Storage Instructions : Store at 2C to 8C. Do not freeze. Dosage Form : Injection Feature : Other, Polyclonal antibody preparation against human Tlymphocytes Indication : Used for the treatment of renal transplantation rejection and aplastic anemia Shelf Life : 24 months from manufacture Application : Other, Intravenous administration in clinical settings Ingredients : Other , Antithymocyte Globulin, Water for Injection, and excipients Salt Composition : Antithymocyte Immunoglobulin (Equine) Physical Color/Texture : Other , Clear to slightly opalescent liquid Fermentation Smell : Other, Odorless Enzyme Types : Other, Not applicable (Immunoglobulinbased Biologic) Ph Level : Near neutral (usually around 6.08.0, pharmaceutical standard)

Send Inquiry

Reditux Injection Storage Instructions : Store at 2C to 8C. Do not freeze. Protect from light. Dosage Form : Injection Feature : Other, Chimeric monoclonal antibody, targets CD20 antigen Indication : NonHodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis Shelf Life : 24 months from manufacturing date Application : Other, Used in oncology and autoimmune disease treatment Ingredients : Other , Rituximab (active), excipients and buffers Salt Composition : Rituximab Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution Fermentation Smell : Other, Odorless Enzyme Types : Other, Not applicable (Monoclonal antibody) Ph Level : 6.5 7.0 (approximate)

Send Inquiry

5-fluorouracil Injection Storage Instructions : Store below 25C. Protect from light. Do not freeze. Dosage Form : Injection Feature : Other, Sterile, preservativefree, readytouse injectable cytotoxic solution Indication : Antineoplastic agent used in the treatment of cancer, particularly colorectal, breast, stomach, and pancreatic cancers Shelf Life : 24 months Application : Other, Intravenous administration in oncology protocols Ingredients : Other , Active ingredient: 5Fluorouracil; Excipients: Water for Injection, Sodium Hydroxide (for pH adjustment) Salt Composition : 5Fluorouracil 500 mg / 10 ml Physical Color/Texture : Other , Colorless to slightly yellow, clear, aqueous solution Enzyme Types : Other, Not applicable (Chemotherapeutic/Antimetabolite) Ph Level : 8.6 9.0

Send Inquiry

Epirubicin EHCL Injection Storage Instructions : Store below 25C, protect from light Dosage Form : Injection Feature : Other, Sterile, readytouse, singledose or multidose vial Indication : Treatment of breast cancer and other malignancies Shelf Life : 24 Months Application : Other, IV administration for oncology usage Ingredients : Other , Epirubicin Hydrochloride, Water for Injection, Excipients Salt Composition : Epirubicin Hydrochloride Physical Color/Texture : Other , Red, clear solution Fermentation Smell : Other, Odorless Ph Level : 3.0 4.5 (approximate)

Send Inquiry

SEND INQUIRY CALL ME FREE

We Mainly Deal in International Market.